United States · FDA National Drug Code directory
HFM CORD
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 44911-0601_632dc16d-3460-4a92-b544-3cffeb66ab6c
- Product NDC
- 44911-0601
- Form
- LIQUID
- Composition / generic term
- Coxsackie Nosode A3, A4, A5, A7, B1, B3, B5
- Labeler
- Energique, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20210524
- Source listing expiry
- 20261231
Source-listed ingredients
- HUMAN COXSACKIEVIRUS A — 6 [hp_C]/mL
- HUMAN COXSACKIEVIRUS A7 — 6 [hp_C]/mL
- HUMAN COXSACKIEVIRUS B — 6 [hp_C]/mL
- HUMAN COXSACKIEVIRUS B1 — 6 [hp_C]/mL
- HUMAN COXSACKIEVIRUS B3 — 12 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (44911-0601-1) · 44911-0601-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →